ArticleEuropean journal of neurology2026

Efficacy and Safety of Rituximab Versus Inebilizumab in Patients With Neuromyelitis Optica Spectrum Disorder: A Dual-Center, Real-World Cohort Study.

Ying Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.